Terms: = Brain cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Prognosis
164 results:
1. Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach.
Kartal B; Denizler-Ebiri FN; Güven M; Taşpınar F; Canpınar H; Çetin S; Karaduman T; Küççüktürk S; Castresana J; Taşpınar M
Med Oncol; 2024 Mar; 41(5):97. PubMed ID: 38532150
[TBL] [Abstract] [Full Text] [Related]
2. MAEL in human cancers and implications in prognostication and predicting benefit from immunotherapy over VEGFR/mtor inhibitors in clear cell renal cell carcinoma: a bioinformatic analysis.
Tao J; Cui J; Xu Y; Fan Y; Hong G; Zhou Q; Wang G; Li L; Han Y; Xu C; Wang W; Cai S; Zhang X
Aging (Albany NY); 2024 Jan; 16(3):2090-2122. PubMed ID: 38301040
[No Abstract] [Full Text] [Related]
3. Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors.
Zhang Y; Zhong C; Ke X; Liu J; Ye Z; Lu L; Deng K; Zhu H; Yao Y
Acta Neuropathol Commun; 2023 Nov; 11(1):188. PubMed ID: 38012690
[TBL] [Abstract] [Full Text] [Related]
4. [New treatment strategies for primary lymphoma of the central nervous system].
Seidel S; Kaulen L; von Baumgarten L
Nervenarzt; 2024 Feb; 95(2):117-124. PubMed ID: 37910181
[TBL] [Abstract] [Full Text] [Related]
5. SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic cancer.
Kim MJ; Kim HS; Kang HW; Lee DE; Hong WC; Kim JH; Kim M; Cheong JH; Kim HJ; Park JS
Cells; 2023 Oct; 12(20):. PubMed ID: 37887353
[TBL] [Abstract] [Full Text] [Related]
6. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
[TBL] [Abstract] [Full Text] [Related]
7. Toward Precision Oncology in Glioblastoma with a Personalized cancer Genome Reporting Tool and Genetic Changes Identified by Whole Exome Sequencing.
Erdogan O; Özkaya ŞÇ; Erzik C; Bilguvar K; Arga KY; Bayraklı F
OMICS; 2023 Sep; 27(9):426-433. PubMed ID: 37669106
[TBL] [Abstract] [Full Text] [Related]
8. RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mtor pathway.
Liang L; Zhao Z; Jin Q; Zhang S; Zhao Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):80-86. PubMed ID: 37571896
[TBL] [Abstract] [Full Text] [Related]
9. MiR-4524b-5p-targeting ALDH1A3 attenuates the proliferation and radioresistance of glioblastoma via PI3K/AKT/mtor signaling.
Yu H; Li X; Li Y; Wang T; Wang M; Mao P
CNS Neurosci Ther; 2024 Feb; 30(2):e14396. PubMed ID: 37551838
[TBL] [Abstract] [Full Text] [Related]
10. Novel therapeutic strategies in glioma targeting glutamatergic neurotransmission.
Kumaria A; Ashkan K
Brain Res; 2023 Nov; 1818():148515. PubMed ID: 37543066
[TBL] [Abstract] [Full Text] [Related]
11. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.
Ji S; Feng L; Fu Z; Wu G; Wu Y; Lin Y; Lu D; Song Y; Cui P; Yang Z; Sang C; Song G; Cai S; Li Y; Lin H; Zhang S; Wang X; Qiu S; Zhang X; Hua G; Li J; Zhou J; Dai Z; Wang X; Ding L; Wang P; Gao D; Zhang B; Rodriguez H; Fan J; Clevers H; Zhou H; Sun Y; Gao Q
Sci Transl Med; 2023 Jul; 15(706):eadg3358. PubMed ID: 37494474
[TBL] [Abstract] [Full Text] [Related]
12. RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer.
Li YQ; Sun FZ; Li CX; Mo HN; Zhou YT; Lv D; Zhai JT; Qian HL; Ma F
Mil Med Res; 2023 Jul; 10(1):34. PubMed ID: 37491281
[TBL] [Abstract] [Full Text] [Related]
13. A prognostic biomarker NRG1 promotes U-87 MG glioblastoma cell malignancy by inhibiting autophagy via ERBB2/AKT/mtor pathway.
Lin JZ; Lin N; Zhao WJ
J Cell Biochem; 2023 Sep; 124(9):1273-1288. PubMed ID: 37450666
[TBL] [Abstract] [Full Text] [Related]
14. Machine learning to improve interpretability of clinical, radiological and panel-based genomic data of glioma grade 4 patients undergoing surgical resection.
Dal Bo M; Polano M; Ius T; Di Cintio F; Mondello A; Manini I; Pegolo E; Cesselli D; Di Loreto C; Skrap M; Toffoli G
J Transl Med; 2023 Jul; 21(1):450. PubMed ID: 37420248
[TBL] [Abstract] [Full Text] [Related]
15. SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
Xue Z; Wang J; Wang Z; Liu J; Zhao J; Liu X; Zhang Y; Liu G; Zhao Z; Li W; Zhang Q; Li X; Huang B; Wang X
BMC Cancer; 2023 Jun; 23(1):589. PubMed ID: 37365560
[TBL] [Abstract] [Full Text] [Related]
16. Case Report: brainstem angiocentric glioma presenting in a toddler child-diagnostic and therapeutic challenges.
Reisz Z; Radics BL; Nemes P; Laxton R; Kaizer L; Gabor KM; Novak T; Barzo P; Al-Sarraj S; Bodi I
Pathol Oncol Res; 2023; 29():1611231. PubMed ID: 37362245
[No Abstract] [Full Text] [Related]
17. Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
Smyth EN; John J; Tiu RV; Willard MD; Beyrer JK; Bowman L; Sheffield KM; Han Y; Brastianos PK
Oncologist; 2023 Nov; 28(11):e1075-e1091. PubMed ID: 37358877
[TBL] [Abstract] [Full Text] [Related]
18. Overexpression of Podoplanin Predicts Poor prognosis in Patients With Glioma.
He J; Zhang G; Yuan Q; Wang S; Liu Z; Wang M; Cai H; Wan J; Zhao B
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):295-303. PubMed ID: 37093708
[TBL] [Abstract] [Full Text] [Related]
19. Predictive significance of PRR11 in prognosis and immune infiltration of glioma patients.
Han W; Chen L
Mol Carcinog; 2023 Jul; 62(7):975-990. PubMed ID: 37036189
[TBL] [Abstract] [Full Text] [Related]
20. MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mtor pathway.
Ren J; Zheng S; Zhang L; Liu J; Cao H; Wu S; Xu Y; Sun J
Cancer Med; 2023 May; 12(10):11624-11640. PubMed ID: 36999945
[TBL] [Abstract] [Full Text] [Related]
[Next]